New cancer drug enters early human testing for solid tumors and leukemia
NCT ID NCT05768932
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This early-stage study tests a new drug called BAL0891, given alone or with chemotherapy or immunotherapy, in people with advanced solid tumors or relapsed acute myeloid leukemia (AML). The main goals are to check safety and find the best dose. About 260 adults will take part across multiple groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, South Korea
Contact
-
Korean University Anam Hospital
RECRUITINGSeoul, South Korea
Contact
-
Mary Crowley Cancer Research
WITHDRAWNDallas, Texas, 75230, United States
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10461, United States
Contact
-
OHSU Knight Cancer Institute
ACTIVE_NOT_RECRUITINGPortland, Oregon, 97239, United States
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
Contact
-
Seoul National University Hospital
RECRUITINGSeoul, South Korea
Contact
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, South Korea
Contact
-
The Catholic University of Korea, Seoul St. Mary's Hospital
RECRUITINGSeoul, 06591, South Korea
Contact
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
University of Miami Health System
RECRUITINGCoral Gables, Florida, 33146, United States
Contact
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
-
Weill Cornell Medicine- NewYork-Presbyterian Hospital
RECRUITINGNew York, New York, 10021, United States
Contact
-
Winship Cancer Institute / Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
Yale New Haven Hospital
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Conditions
Explore the condition pages connected to this study.